Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer
Clinical trial NCT05535569 · COMPLETED
Trial details
- NCT number
- NCT05535569
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-17
- Primary completion
- 2021-11-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.